{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:54:11Z","timestamp":1761490451721},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Meningitis Research Foundation, U.K.","award":["0906.1"],"award-info":[{"award-number":["0906.1"]}]},{"name":"Oxford Partnership Comprehensive Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2018.01.031","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T01:28:31Z","timestamp":1517534911000},"page":"1297-1303","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007"],"prefix":"10.1016","volume":"36","author":[{"given":"Gunnstein","family":"Norheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe-Marie","family":"Njanpop-Lafourcade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Delrieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Nagaputra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Dold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsidi Agbeko","family":"Tamekloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abiba Banla","family":"Kere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth M.","family":"N\u00e6ss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.01.031_b0005","first-page":"1","article-title":"Cerebrospinal meningitis in Africa","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.01.031_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","article-title":"Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa","volume":"3","author":"Molesworth","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.01.031_b0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson Lecture. Meningococcal meningitis in Africa","volume":"4","author":"Greenwood","year":"1999","journal-title":"Trans R Soc TropMed Hyg"},{"key":"10.1016\/j.vaccine.2018.01.031_b0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"5","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3201\/eid1306.070042","article-title":"Serogroup X meningococcal disease, Western Kenya","volume":"16","author":"Materu","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0030","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.vaccine.2013.04.036","article-title":"Emergence of serogroup X meningococcal disease in Africa: need for a vaccine","volume":"27","author":"Xie","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0035","unstructured":"World Health Organization. Fact sheet N\u00b0141. Meningococcal meningitis. Geneva, Switzerland; 2011. http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/."},{"key":"10.1016\/j.vaccine.2018.01.031_b0040","doi-asserted-by":"crossref","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","article-title":"Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso","volume":"5","author":"Delrieu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.01.031_b0045","unstructured":"World Health Organization. Meningitis Weekly Bulletin, Week 25. Meningococcal disease control in countries of the African meningitis belt, 2014. West-Africa Inter-Country Support Team. Ouagadougou, Burkina Faso: World Health Organization; 2015."},{"issue":"1","key":"10.1016\/j.vaccine.2018.01.031_b0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3201\/eid2201.150432","article-title":"Surveillance of Bacterial Meningitis, Ethiopia, 2012\u20132013","volume":"22","author":"Mihret","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0060","first-page":"1298","article-title":"The diversity of Meningococcal Carriage across the African Meningitis belt and the impact of vaccination with a group A Meningococcal conjugate vaccine","volume":"8","author":"MenAfriCar consortium","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0065","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1073\/pnas.1314476110","article-title":"Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X","volume":"47","author":"Micoli","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.01.031_b0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biologicals.2013.12.001","article-title":"Process development and immunogenicity studies on a serogroup X meningococcal polysaccharide conjugate vaccine","volume":"3","author":"Chilukuri","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.01.031_b0075","first-page":"2367","article-title":"Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments","volume":"10","author":"Morelli","year":"2014","journal-title":"J Org Chem"},{"key":"10.1016\/j.vaccine.2018.01.031_b0080","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"9","author":"Beernink","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0085","unstructured":"Norheim G, Tunheim G, Naess LM, Bolstad K, Fjeldheim \u00c5K, Garcia L, Cardoso D, Caridad Z, Acevedo R, Rosenqvist E. 2012. A trivalent outer membrane vesicle (OMV) vaccine against serogroup A, W-135 and X meningococcal disease. In: Proceedings from XVIIIth International Pathogenic Neisseria Conference, September 2012. W\u00fcrzburg, Germany."},{"key":"10.1016\/j.vaccine.2018.01.031_b0090","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"9","author":"Pajon","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0095","doi-asserted-by":"crossref","first-page":"e79304","DOI":"10.1371\/journal.pone.0079304","article-title":"The development of an experimental multiple serogroups vaccine for Neisseria meningitidis","volume":"11","author":"Pinto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.01.031_b0100","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1016\/j.vaccine.2014.09.063","article-title":"Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt","volume":"49","author":"Tunheim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0105","doi-asserted-by":"crossref","first-page":"e0147928","DOI":"10.1371\/journal.pone.0147928","article-title":"A seroepidemiological study of serogroup A Meningococcal infection in the African Meningitis belt","volume":"2","author":"Manigart","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.01.031_b0110","doi-asserted-by":"crossref","first-page":"e55486","DOI":"10.1371\/journal.pone.0055486","article-title":"Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008","volume":"2","author":"Trotter","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.01.031_b0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14760584.5.3.319","article-title":"Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines","volume":"3","author":"Mueller","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.01.031_b0120","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1086\/500511","article-title":"Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003","volume":"6","author":"Mueller","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0125","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/infdis\/jir623","article-title":"Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity","volume":"11","author":"Mueller","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/CVI.05515-11","article-title":"Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009","volume":"2","author":"Trotter","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.01.031_b0135","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1016\/j.vaccine.2012.07.032","article-title":"Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies","volume":"40","author":"Xie","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CVI.00008-07","article-title":"Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7","volume":"4","author":"Norheim","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.01.031_b0145","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.02.021","article-title":"Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis","volume":"29","author":"Norheim","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/cdli.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The multilaboratory study group","volume":"2","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.01.031_b0155","doi-asserted-by":"crossref","first-page":"A47","DOI":"10.1016\/j.vaccine.2007.04.040","article-title":"The epidemiology of Neisseria meningitidis meningitis in Togo during 2003\u20132005","volume":"25","author":"Adjogble","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0160","first-page":"76","article-title":"WHO Child Growth Standards based on length\/height, weight and age","volume":"450","author":"World Health Organization","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2018.01.031_b0165","series-title":"Invasive Neisseria meningitidis in Europe 2006","author":"Network","year":"2006"},{"key":"10.1016\/j.vaccine.2018.01.031_b0170","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/infdis\/jir466","article-title":"Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation","volume":"7","author":"Ibarz-Pavon","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0175","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age","volume":"5","author":"Al-Mazrou","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.01.031_b0180","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2004.07.042","article-title":"Naturally-acquired immunity to Neisseria meningitidis group A","volume":"8","author":"Amir","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0185","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1016\/j.vaccine.2014.04.052","article-title":"The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines","volume":"33","author":"Idoko","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.031_b0190","doi-asserted-by":"crossref","first-page":"17871","DOI":"10.1073\/pnas.1114489108","article-title":"Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2","volume":"44","author":"Robbins","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.01.031_b0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/135.1.94","article-title":"Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92","volume":"1","author":"Glode","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0200","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/iai.13.6.1654-1662.1976","article-title":"Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide","volume":"6","author":"Vann","year":"1976","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.01.031_b0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2014.07.022","article-title":"The case of a new sequence type 7 serogroup X Neisseria meningitidis infection in China: may capsular switching change serogroup profile?","volume":"29","author":"Pan","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.031_b0210","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/JCM.43.10.5129-5135.2005","article-title":"Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes","volume":"10","author":"Nicolas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.01.031_b0215","unstructured":"LaForce M. Progress on MenACWYX vaccine: phase 1 trial results. In: Conference Abstract. Meningitis Research Foundation: meningitis and septicaemia in children and adults. 14\u201315 November. London, U.K.; 2017."},{"key":"10.1016\/j.vaccine.2018.01.031_b0220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","article-title":"Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?","volume":"31","author":"Hong","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2018.01.031_b0225","doi-asserted-by":"crossref","first-page":"S554","DOI":"10.1093\/cid\/civ504","article-title":"Human complement bactericidal responses to a group a meningococcal conjugate vaccine in africans and comparison to responses measured by 2 other group a immunoassays","volume":"61","author":"Price","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:06:05Z","timestamp":1668639965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18300665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X18300665"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}